235 related articles for article (PubMed ID: 33757676)
21. Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.
Carrasco CA; García M; Goycoolea M; Cerda J; Bertherat J; Padilla O; Meza D; Wohllk N; Quiroga T
Endocrine; 2012 Jun; 41(3):487-93. PubMed ID: 22270871
[TBL] [Abstract][Full Text] [Related]
22. Late-Night Salivary Cortisol: Cut-Off Definition and Diagnostic Accuracy for Cushing's Syndrome in a Portuguese Population.
Lages AS; Frade JG; Oliveira D; Paiva I; Oliveira P; Rebelo-Marques A; Carrilho F
Acta Med Port; 2019 May; 32(5):381-387. PubMed ID: 31166899
[TBL] [Abstract][Full Text] [Related]
23. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome.
Carroll T; Raff H; Findling JW
Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):344-50. PubMed ID: 18446140
[TBL] [Abstract][Full Text] [Related]
24. Cushing's syndrome: diagnosis and surveillance using salivary cortisol.
Raff H
Pituitary; 2012 Mar; 15(1):64-70. PubMed ID: 21833616
[TBL] [Abstract][Full Text] [Related]
25. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.
Esfahanian F; Kazemi R
Acta Med Iran; 2010; 48(4):222-5. PubMed ID: 21279933
[TBL] [Abstract][Full Text] [Related]
26. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome.
Kidambi S; Raff H; Findling JW
Eur J Endocrinol; 2007 Dec; 157(6):725-31. PubMed ID: 18057379
[TBL] [Abstract][Full Text] [Related]
27. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and differential diagnosis of Cushing's syndrome].
Santos S; Santos E; Gaztambide S; Salvador J
Endocrinol Nutr; 2009 Feb; 56(2):71-84. PubMed ID: 19627715
[TBL] [Abstract][Full Text] [Related]
29. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.
Findling JW; Fleseriu M; Newell-Price J; Petersenn S; Pivonello R; Kandra A; Pedroncelli AM; Biller BM
Endocrine; 2016 Nov; 54(2):516-523. PubMed ID: 27209465
[TBL] [Abstract][Full Text] [Related]
30. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
Carroll TB; Javorsky BR; Findling JW
Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
[TBL] [Abstract][Full Text] [Related]
31. Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population.
Aberle J; Schulze Zur Wiesch C; Flitsch J; Veigel J; Schön G; Jung R; Reining F; Lautenbach A; Rotermund R; Riedel N
J Endocrinol Invest; 2018 Nov; 41(11):1325-1331. PubMed ID: 29550934
[TBL] [Abstract][Full Text] [Related]
32. Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing's syndrome).
Raff H
Pituitary; 2022 Oct; 25(5):698-700. PubMed ID: 35334030
[TBL] [Abstract][Full Text] [Related]
33. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
[TBL] [Abstract][Full Text] [Related]
34. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
Yaneva M; Mosnier-Pudar H; Dugué MA; Grabar S; Fulla Y; Bertagna X
J Clin Endocrinol Metab; 2004 Jul; 89(7):3345-51. PubMed ID: 15240613
[TBL] [Abstract][Full Text] [Related]
35. Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing's syndrome.
Elias PC; Martinez EZ; Barone BF; Mermejo LM; Castro M; Moreira AC
J Clin Endocrinol Metab; 2014 Jun; 99(6):2045-51. PubMed ID: 24628557
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing's syndrome.
Sakihara S; Kageyama K; Oki Y; Doi M; Iwasaki Y; Takayasu S; Moriyama T; Terui K; Nigawara T; Hirata Y; Hashimoto K; Suda T
Endocr J; 2010; 57(4):331-7. PubMed ID: 20139634
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
[TBL] [Abstract][Full Text] [Related]
39. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
[TBL] [Abstract][Full Text] [Related]
40. Is late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes?
Ellis E; Chin PK; Hunt PJ; Lunt H; Lewis JG; Soule SG
N Z Med J; 2012 Apr; 125(1353):47-58. PubMed ID: 22522271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
